PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

The Small Molecule NLRP3 Inflammasome Inhibitor MCC950 Does Not Alter Wound Healing in Obese Mice.

Mouse / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30360489 ↗2018Reported harm

The Small Molecule NLRP3 Inflammasome Inhibitor MCC950 Does Not Alter Wound Healing in Obese Mice.

MouseWoundC57Bl/6J and Ob/Ob (on a C57Bl/6J background)Male and femalen = 5 control versus 5 treated mice per group per time point, f…Topical (pluronic gel) and oral (drinking water)Topical 1 mg per dose per day in 30% F-127 pluronic gel; or…Topical treatment daily from day 0 to day 4 after wounding

Model: Full-thickness excisional skin wounds (acute wounds in C57Bl/6J mice and impaired healing wounds in obese Ob/Ob mice)

Topical MCC950 produced no significant difference in wound surface compared with gel alone in C57Bl/6J mice and significantly impaired macroscopic wound closure in obese Ob/Ob mice, while re-epithelialisation at day 5 was unchanged. Macrophage numbers and M1 and M2 polarisation in Ob/Ob wounds were…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.